Antengene (FRA:722) Total Tax Payable : €1.54 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Antengene Total Tax Payable?

Antengene's Total Tax Payable for the quarter that ended in Jun. 2024 was €1.54 Mil.

Antengene's quarterly Total Tax Payable increased from Jun. 2023 (€1.56 Mil) to Dec. 2023 (€1.69 Mil) but then declined from Dec. 2023 (€1.69 Mil) to Jun. 2024 (€1.54 Mil).

Antengene's annual Total Tax Payable increased from Dec. 2021 (€0.62 Mil) to Dec. 2022 (€1.71 Mil) but then declined from Dec. 2022 (€1.71 Mil) to Dec. 2023 (€1.69 Mil).

Antengene Total Tax Payable Historical Data

The historical data trend for Antengene's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antengene Total Tax Payable Chart

Antengene Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Tax Payable

Get a 7-Day Free Trial

0.39

0.62

1.71

1.69

0.75

Antengene Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Tax Payable	Get a 7-Day Free Trial								1.71	1.56	1.69	1.54	0.75

Antengene Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Antengene Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Antengene's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Antengene Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Antengene Corp Ltd (FRA:722) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

06996:Hong Kong 722:Germany

Address

1065 West Zhongshan Road, Suites 1206-1209, Block B, Zhongshan SOHO Plaza, Changning District, Shanghai, CHN

Website

https://www.antengene.com

Antengene Corp Ltd is a clinical-stage biopharmaceutical company focused on oncology medicines. The company produces drugs such as selinexor, eltanexor, verdinexor, and other products. It also engages in the discovery, development, manufacturing, and commercialization of first-in-class therapeutics for the treatment of hematologic malignancies and solid tumors. Geographically it operates in Chinese Mainland, Hong Kong, Macao and Taiwan and Overseas.

Antengene Headlines

No Headlines